Landos Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 20 shareholders own 61.61% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
47.6%	Perceptive Advisors LLC	1,486,991	US$34.1m	0%	0.66%
9.89%	Xontogeny LLC	309,092	US$7.1m	0%	no data
1.6%	Deltec Asset Management LLC	50,000	US$1.1m	0%	0.23%
0.6%	Renaissance Technologies LLC	18,890	US$433.1k	67.8%	no data
0.47%	Macquarie Investment Management Business Trust	14,718	US$337.5k	0%	no data
0.47%	Virtu Financial LLC, Asset Management Arm	14,537	US$333.3k	0%	0.03%
0.4%	Geode Capital Management, LLC	12,604	US$289.0k	0%	no data
0.33%	Black Maple Capital Management LP	10,405	US$238.6k	0%	0.16%
0.13%	UBS Asset Management AG	4,084	US$93.6k	9,620%	no data
0.077%	The Vanguard Group, Inc.	2,399	US$55.0k	0%	no data
0.029%	Tower Research Capital LLC	896	US$20.5k	0%	no data
0.019%	Bg Fund Management Luxembourg S.A.	606	US$13.9k	0%	no data
0.0078%	GF Fund Management Co., Ltd.	243	US$5.6k	0%	no data
0.0043%	Acadian Asset Management LLC	134	US$3.1k	0%	no data
0.0019%	Royal Bank of Canada, Banking & Securities Investments	61	US$1.4k	0%	no data
0.0019%	JPMorgan Chase & Co, Brokerage and Securities Investments	59	US$1.4k	0%	no data
0.00042%	Morgan Stanley, Investment Banking and Brokerage Investments	13	US$301.0	0%	no data
0.00038%	Cornerstone Planning Group Inc.	12	US$272.4	0%	no data
0.00032%	Wells Fargo & Company, Private Banking and Investment Banking Arm	10	US$229.4	0%	no data
0.00006%	Guggenheim Partners, LLC	2	US$43.0	0%	no data